Suresh K. Rayala - Publications

PELP1 expression is associated with disease progression in inflammation-driven oral cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 25, 2026

Emerging biomarkers in breast fibroadenoma: implications for differential diagnosis, malignant transformation, and precision medicine.

Journal: Molecular biology reports

Published: March 03, 2026

AMPK/mTORC2/AKT-473/RUNX2 signaling axis modulates epithelial-mesenchymal transition and bone tropism in breast cancer.

Journal: Frontiers in oncology

Published: January 12, 2026

Sugars to signals: emerging roles of PAK1 in re-wiring glucose metabolism in cancers.

Journal: Expert opinion on therapeutic targets

Published: December 24, 2025

Expression of Transmembrane Glycoprotein TROP2 in Triple-Negative Breast Cancer and It's Potential as a Molecular Classifier for Targeted Therapy.

Journal: Cancer investigation

Published: December 17, 2025

P21-Activated Kinase 1 (PAK1) Modulates Therapeutic Response to Ionizing Radiation in Head and Neck Squamous Cell Carcinoma Cells.

Journal: Molecular carcinogenesis

Published: August 26, 2024

Transcriptome Analysis of Human Pancreatic Stellate Cells Co-cultured With PAK1-Modulated Cells Revealed the Role of Cytokine Pathway in Tumor Microenvironment.

Journal: Pancreas

Published: June 28, 2024

Novel Combination Therapy Targeting Oncogenic Signaling Kinase P21-Activated Kinase 1 and Chemotherapeutic Drugs Against Triple-Negative Breast Cancer.

Journal: Molecular cancer therapeutics

Published: May 31, 2024

Spatio-temporal localization of P21-activated kinase in endometrial cancer.

Journal: Biotechnology and applied biochemistry

Published: May 29, 2024

Next-generation biomarkers for prognostic and potential therapeutic enhancement in Triple negative breast cancer.

Journal: Critical reviews in oncology/hematology

Published: May 01, 2024

Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure.

Journal: Journal of cellular physiology

Published: October 12, 2023

Anti-cancer Application of Nat-ZnFe2O4 Nanoparticles on 2D Tumor Models.

Journal: Applied biochemistry and biotechnology

Published: May 24, 2023